메뉴 건너뛰기




Volumn 20, Issue 11, 2014, Pages 1177-1180

Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease

Author keywords

Ceruloplasmin; MiR 133b; Parkinson's disease

Indexed keywords

CERULOPLASMIN; MICRORNA; MICRORNA 133B; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN133 MICRORNA, HUMAN;

EID: 84908567249     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.08.016     Document Type: Article
Times cited : (46)

References (30)
  • 1
    • 0034663039 scopus 로고    scopus 로고
    • The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity
    • Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., Wolozin B. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. JNeurosci 2000, 20:6048-6054.
    • (2000) JNeurosci , vol.20 , pp. 6048-6054
    • Ostrerova-Golts, N.1    Petrucelli, L.2    Hardy, J.3    Lee, J.M.4    Farer, M.5    Wolozin, B.6
  • 2
    • 0036400025 scopus 로고    scopus 로고
    • Ceruloplasmin metabolism and function
    • Hellman N.E., Gitlin J.D. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002, 22:439-458.
    • (2002) Annu Rev Nutr , vol.22 , pp. 439-458
    • Hellman, N.E.1    Gitlin, J.D.2
  • 3
    • 0038711587 scopus 로고    scopus 로고
    • Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system
    • Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. JBiol Chem 2003, 278:27144-27148.
    • (2003) JBiol Chem , vol.278 , pp. 27144-27148
    • Jeong, S.Y.1    David, S.2
  • 4
    • 84856370491 scopus 로고    scopus 로고
    • Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface
    • Marques L., Auriac A., Willemetz A., Banha J., Silva B., Canonne-Hergaux F., et al. Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface. Blood Cells Mol Dis 2012, 48:110-120.
    • (2012) Blood Cells Mol Dis , vol.48 , pp. 110-120
    • Marques, L.1    Auriac, A.2    Willemetz, A.3    Banha, J.4    Silva, B.5    Canonne-Hergaux, F.6
  • 5
    • 83455177604 scopus 로고    scopus 로고
    • Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention
    • Olivieri S., Conti A., Iannaccone S., Cannistraci C.V., Campanella A., Barbariga M., et al. Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. JNeurosci 2011, 31:18568-18577.
    • (2011) JNeurosci , vol.31 , pp. 18568-18577
    • Olivieri, S.1    Conti, A.2    Iannaccone, S.3    Cannistraci, C.V.4    Campanella, A.5    Barbariga, M.6
  • 6
    • 78649519833 scopus 로고    scopus 로고
    • Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review
    • Torsdottir G., Kristinsson J., Snaedal J., Sveinbjornsdottir S., Gudmundsson G., Hreidarsson S., et al. Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review. JNeurol Sci 2010, 299:51-54.
    • (2010) JNeurol Sci , vol.299 , pp. 51-54
    • Torsdottir, G.1    Kristinsson, J.2    Snaedal, J.3    Sveinbjornsdottir, S.4    Gudmundsson, G.5    Hreidarsson, S.6
  • 7
    • 0033597299 scopus 로고    scopus 로고
    • Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
    • Boll M.C., Sotelo J., Otero E., Alcaraz-Zubeldia M., Rios C. Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci Lett 1999, 265:155-158.
    • (1999) Neurosci Lett , vol.265 , pp. 155-158
    • Boll, M.C.1    Sotelo, J.2    Otero, E.3    Alcaraz-Zubeldia, M.4    Rios, C.5
  • 8
    • 84878398613 scopus 로고    scopus 로고
    • Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
    • Ayton S., Lei P., Duce J.A., Wong B.X., Sedjahtera A., Adlard P.A., et al. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 2013, 73:554-559.
    • (2013) Ann Neurol , vol.73 , pp. 554-559
    • Ayton, S.1    Lei, P.2    Duce, J.A.3    Wong, B.X.4    Sedjahtera, A.5    Adlard, P.A.6
  • 9
    • 67349173208 scopus 로고    scopus 로고
    • Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease
    • Bharucha K.J., Friedman J.K., Vincent A.S., Ross E.D. Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease. JNeurol 2008, 255:1957-1962.
    • (2008) JNeurol , vol.255 , pp. 1957-1962
    • Bharucha, K.J.1    Friedman, J.K.2    Vincent, A.S.3    Ross, E.D.4
  • 10
    • 78650695967 scopus 로고    scopus 로고
    • Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease
    • Jin L., Wang J., Zhao L., Jin H., Fei G., Zhang Y., et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 2011, 134:50-58.
    • (2011) Brain , vol.134 , pp. 50-58
    • Jin, L.1    Wang, J.2    Zhao, L.3    Jin, H.4    Fei, G.5    Zhang, Y.6
  • 11
    • 84862799577 scopus 로고    scopus 로고
    • Nigral iron deposition occurs across motor phenotypes of Parkinson's disease
    • Jin L., Wang J., Jin H., Fei G., Zhang Y., Chen W., et al. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease. Eur J Neurol 2012, 19:969-976.
    • (2012) Eur J Neurol , vol.19 , pp. 969-976
    • Jin, L.1    Wang, J.2    Jin, H.3    Fei, G.4    Zhang, Y.5    Chen, W.6
  • 12
    • 80054992416 scopus 로고    scopus 로고
    • Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study
    • Martinez-Hernandez R., Montes S., Higuera-Calleja J., Yescas P., Boll M.C., Diaz-Ruiz A., et al. Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study. Neurochem Res 2011, 36:2111-2115.
    • (2011) Neurochem Res , vol.36 , pp. 2111-2115
    • Martinez-Hernandez, R.1    Montes, S.2    Higuera-Calleja, J.3    Yescas, P.4    Boll, M.C.5    Diaz-Ruiz, A.6
  • 13
    • 0028040512 scopus 로고
    • Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions
    • Petrukhin K., Lutsenko S., Chernov I., Ross B.M., Kaplan J.H., Gilliam T.C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994, 3:1647-1656.
    • (1994) Hum Mol Genet , vol.3 , pp. 1647-1656
    • Petrukhin, K.1    Lutsenko, S.2    Chernov, I.3    Ross, B.M.4    Kaplan, J.H.5    Gilliam, T.C.6
  • 14
    • 0035097871 scopus 로고    scopus 로고
    • Is Parkinson's disease the heterozygote form of Wilson's disease: PD= 1/2 WD?
    • Johnson S. Is Parkinson's disease the heterozygote form of Wilson's disease: PD= 1/2 WD?. Med Hypotheses 2001, 56:171-173.
    • (2001) Med Hypotheses , vol.56 , pp. 171-173
    • Johnson, S.1
  • 15
    • 70349229546 scopus 로고    scopus 로고
    • Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation
    • Lirong J., Jianjun J., Hua Z., Guoqiang F., Yuhao Z., Xiaoli P., et al. Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation. Eur J Neurol 2009, 16:1130-1137.
    • (2009) Eur J Neurol , vol.16 , pp. 1130-1137
    • Lirong, J.1    Jianjun, J.2    Hua, Z.3    Guoqiang, F.4    Yuhao, Z.5    Xiaoli, P.6
  • 16
    • 0035955374 scopus 로고    scopus 로고
    • Identification of novel genes coding for small expressed RNAs
    • Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
    • (2001) Science , vol.294 , pp. 853-858
    • Lagos-Quintana, M.1    Rauhut, R.2    Lendeckel, W.3    Tuschl, T.4
  • 17
    • 58249088751 scopus 로고    scopus 로고
    • MicroRNAs: target recognition and regulatory functions
    • Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
    • (2009) Cell , vol.136 , pp. 215-233
    • Bartel, D.P.1
  • 18
    • 11844278458 scopus 로고    scopus 로고
    • Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
    • Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
    • (2005) Cell , vol.120 , pp. 15-20
    • Lewis, B.P.1    Burge, C.B.2    Bartel, D.P.3
  • 20
    • 84859500773 scopus 로고    scopus 로고
    • MicroRNAs in Parkinson's disease
    • Mouradian M.M. MicroRNAs in Parkinson's disease. Neurobio Dis 2012, 46:279-284.
    • (2012) Neurobio Dis , vol.46 , pp. 279-284
    • Mouradian, M.M.1
  • 22
    • 0032937059 scopus 로고    scopus 로고
    • Diagnostic criteria for Parkinson disease
    • Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
    • (1999) Arch Neurol , vol.56 , pp. 33-39
    • Gelb, D.J.1    Oliver, E.2    Gilman, S.3
  • 23
    • 0014082977 scopus 로고
    • Parkinsonism: onset, progression and mortality
    • Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
    • (1967) Neurology , vol.17 , pp. 427-442
    • Hoehn, M.M.1    Yahr, M.D.2
  • 25
    • 84876183915 scopus 로고    scopus 로고
    • MiRNAs and their putative roles in the development and progression of Parkinson's disease
    • Wong G., Nass R. miRNAs and their putative roles in the development and progression of Parkinson's disease. Front Genet 2012, 3:315.
    • (2012) Front Genet , vol.3 , pp. 315
    • Wong, G.1    Nass, R.2
  • 26
    • 84864862893 scopus 로고    scopus 로고
    • Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice
    • Heyer M.P., Pani A.K., Smeyne R.J., Kenny P.J., Feng G. Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. JNeurosci 2012, 32:10887-10894.
    • (2012) JNeurosci , vol.32 , pp. 10887-10894
    • Heyer, M.P.1    Pani, A.K.2    Smeyne, R.J.3    Kenny, P.J.4    Feng, G.5
  • 30
    • 0036703490 scopus 로고    scopus 로고
    • Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
    • Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. JNeurosci 2002, 22:6578-6586.
    • (2002) JNeurosci , vol.22 , pp. 6578-6586
    • Patel, B.N.1    Dunn, R.J.2    Jeong, S.Y.3    Zhu, Q.4    Julien, J.P.5    David, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.